Do intensive lipid-lowering treatments achieving very low LDL-C levels reduce cardiovascular events without increasing adverse events?
Achieving very low LDL-C levels with intensive lipid-lowering therapy is safe and continues to reduce cardiovascular events.
This meta-analysis indicates that very low LDL-C levels on intensive lipid-lowering treatments are not associated with any adverse event and maintain a persistent reduction of cardiovascular events.
Patti et al. (2022) studied this question.